Fact CheckerSign in

NCT04165616Active, not recruiting

Motor rECovery witH eArly imagiNg In STroke

MECHANIST: Motor rECovery witH eArly imagiNg In STroke

Source: ClinicalTrials.gov · Last updated 2 Sept 2026

Brief summary (registry, in English)

This study will contribute to the field of stroke rehabilitation research by expanding the investigator's understanding of the neural mechanisms responsible for the development and expression of abnormal flexion synergy, a primary movement impairment due to stroke. The study will longitudinally evaluate motor tract morphology and motor impairment/function in an attempt to develop early neuroimaging-based predictors of the development of flexion synergy and its impact on reaching and hand recovery (6 month). The study will utilize quantitative motor testing (kinematics and kinetics) to measure motor impairment and reaching and hand function. Both neuroimaging and quantitative motor testing will be conducted within 96 hours-, 2 weeks-, 3 months-, and 6 months-post stroke. The knowledge gained by this study will provide crucial structural and functional neuroimaging evidence that demonstrates the timeline of progressive ipsi- and contralesional motor pathway (including bulbospinal pathways) changes and the associated development of flexion synergy that grossly impacts reaching and hand function in individuals with moderate to severe stroke.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
120 (estimated)
First submitted
30 Oct 2019
Start date
21 Jun 2022
Primary completion date
13 Jul 2026
Lead sponsor
Northwestern University
Diseases
Stroke
NCT number
NCT04165616

What you commit to

  • Study type: Observational
  • Planned participants: 120
  • From 21 Jun 2022 to the primary completion date, 13 Jul 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Premorbid disability or sensorimotor impairment
  • Pain or hypersensitivity limiting motor assessment

Other

  • Comorbidity medically contraindicating the administration of subsequent MRI scanning and motor assessments
  • Limb edema limiting motor assessment

Who the study is looking for

  • Stroke within the middle cerebral artery distribution based on brain MRI done within 48 hours of admission
  • 18 to 85 years old
  • Isolated motor deficits (hemiparesis) without significant aphasia, visual disturbances, or neglect based on the following scores on the NIH Stroke Scale: 1a (level of consciousness) = 0- Alert; keenly responsive. 1b (LOC questions) = 0- Asked month and age; Answers both correctly. 1c (LOC commands) = 0- Asked to open/close eyes, grasp/release hand; Performs both correctly. 2 (Best Gaze) = 0- Horizontal eye movements; Normal. 5 (Motor Arm) = 1, 2, 3, or 4- Arm placed at 90 (sitting) or 45 (supine), Drift, Some effort, No effort against gravity, or No movement. 7 (Limb Ataxia) = 0- Finger-nose-finger or heel-shin test; Absent. 8 (Sensory) = 0 or 1- Pin prick; Normal or Mild-to-moderate sensory loss. 9 (Best Language) = 0 or 1- Describe picture; No or Mild-to-moderate Aphasia. 11 (Extinction and Inattention) = 0 or 1- No abnormality or Inattention to one modality.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shirley Ryan AbilityLab
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status
Northwestern Memorial Hospital
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status
Department of Physical Therapy and Human Movement Sciences
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.